408 related articles for article (PubMed ID: 15496457)
21. VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity.
Takahashi N; Miner LL; Sora I; Ujike H; Revay RS; Kostic V; Jackson-Lewis V; Przedborski S; Uhl GR
Proc Natl Acad Sci U S A; 1997 Sep; 94(18):9938-43. PubMed ID: 9275230
[TBL] [Abstract][Full Text] [Related]
22. Electron microscopic immunolabeling of transporters and receptors identifies transmitter-specific functional sites envisioned in Cajal's neuron.
Pickel VM; Garzón M; Mengual E
Prog Brain Res; 2002; 136():145-55. PubMed ID: 12143378
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of brain vesicular monoamine transporter (VMAT2) enhances 1-methyl-4-phenylpyridinium neurotoxicity in vivo in rat striata.
Staal RG; Sonsalla PK
J Pharmacol Exp Ther; 2000 May; 293(2):336-42. PubMed ID: 10773000
[TBL] [Abstract][Full Text] [Related]
24. The neuronal monoamine transporter VMAT2 is regulated by the trimeric GTPase Go(2).
Höltje M; von Jagow B; Pahner I; Lautenschlager M; Hörtnagl H; Nürnberg B; Jahn R; Ahnert-Hilger G
J Neurosci; 2000 Mar; 20(6):2131-41. PubMed ID: 10704487
[TBL] [Abstract][Full Text] [Related]
25. Dopamine transporters and neuronal injury.
Miller GW; Gainetdinov RR; Levey AI; Caron MG
Trends Pharmacol Sci; 1999 Oct; 20(10):424-9. PubMed ID: 10498956
[TBL] [Abstract][Full Text] [Related]
26. Sex-dependent modulation of ethanol consumption in vesicular monoamine transporter 2 (VMAT2) and dopamine transporter (DAT) knockout mice.
Hall FS; Sora I; Uhl GR
Neuropsychopharmacology; 2003 Apr; 28(4):620-8. PubMed ID: 12655306
[TBL] [Abstract][Full Text] [Related]
27. Dopamine transporter and vesicular monoamine transporter knockout mice : implications for Parkinson's disease.
Miller GW; Wang YM; Gainetdinov RR; Caron MG
Methods Mol Med; 2001; 62():179-90. PubMed ID: 21318776
[TBL] [Abstract][Full Text] [Related]
28. Increased MPTP neurotoxicity in vesicular monoamine transporter 2 heterozygote knockout mice.
Gainetdinov RR; Fumagalli F; Wang YM; Jones SR; Levey AI; Miller GW; Caron MG
J Neurochem; 1998 May; 70(5):1973-8. PubMed ID: 9572281
[TBL] [Abstract][Full Text] [Related]
29. In vivo imaging of intersynaptic vesicle exchange using VGLUT1 Venus knock-in mice.
Herzog E; Nadrigny F; Silm K; Biesemann C; Helling I; Bersot T; Steffens H; Schwartzmann R; Nägerl UV; El Mestikawy S; Rhee J; Kirchhoff F; Brose N
J Neurosci; 2011 Oct; 31(43):15544-59. PubMed ID: 22031900
[TBL] [Abstract][Full Text] [Related]
30. Preferential localization of a vesicular monoamine transporter to dense core vesicles in PC12 cells.
Liu Y; Schweitzer ES; Nirenberg MJ; Pickel VM; Evans CJ; Edwards RH
J Cell Biol; 1994 Dec; 127(5):1419-33. PubMed ID: 7962100
[TBL] [Abstract][Full Text] [Related]
31. Protective actions of the vesicular monoamine transporter 2 (VMAT2) in monoaminergic neurons.
Guillot TS; Miller GW
Mol Neurobiol; 2009 Apr; 39(2):149-70. PubMed ID: 19259829
[TBL] [Abstract][Full Text] [Related]
32. Reduced vesicular storage of dopamine exacerbates methamphetamine-induced neurodegeneration and astrogliosis.
Guillot TS; Shepherd KR; Richardson JR; Wang MZ; Li Y; Emson PC; Miller GW
J Neurochem; 2008 Sep; 106(5):2205-17. PubMed ID: 18643795
[TBL] [Abstract][Full Text] [Related]
33. The cat-1 gene of Caenorhabditis elegans encodes a vesicular monoamine transporter required for specific monoamine-dependent behaviors.
Duerr JS; Frisby DL; Gaskin J; Duke A; Asermely K; Huddleston D; Eiden LE; Rand JB
J Neurosci; 1999 Jan; 19(1):72-84. PubMed ID: 9870940
[TBL] [Abstract][Full Text] [Related]
34. Vesicular glutamate transporters 1 and 2 target to functionally distinct synaptic release sites.
Fremeau RT; Kam K; Qureshi T; Johnson J; Copenhagen DR; Storm-Mathisen J; Chaudhry FA; Nicoll RA; Edwards RH
Science; 2004 Jun; 304(5678):1815-9. PubMed ID: 15118123
[TBL] [Abstract][Full Text] [Related]
35. Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice.
Kilbourn MR; Kuszpit K; Sherman P
Synapse; 2000 Mar; 35(4):250-5. PubMed ID: 10657034
[TBL] [Abstract][Full Text] [Related]
36. Differential regulation of tyrosine hydroxylase in the basal ganglia of mice lacking the dopamine transporter.
Jaber M; Dumartin B; Sagné C; Haycock JW; Roubert C; Giros B; Bloch B; Caron MG
Eur J Neurosci; 1999 Oct; 11(10):3499-511. PubMed ID: 10564358
[TBL] [Abstract][Full Text] [Related]
37. VMAT2-Mediated Neurotransmission from Midbrain Leptin Receptor Neurons in Feeding Regulation.
Xu Y; Lu Y; Xu P; Mangieri LR; Isingrini E; Xu Y; Giros B; Tong Q
eNeuro; 2017; 4(3):. PubMed ID: 28560316
[TBL] [Abstract][Full Text] [Related]
38. Differential quantal release of histamine and 5-hydroxytryptamine from mast cells of vesicular monoamine transporter 2 knockout mice.
Travis ER; Wang YM; Michael DJ; Caron MG; Wightman RM
Proc Natl Acad Sci U S A; 2000 Jan; 97(1):162-7. PubMed ID: 10618388
[TBL] [Abstract][Full Text] [Related]
39. An essential role for vesicular glutamate transporter 1 (VGLUT1) in postnatal development and control of quantal size.
Wojcik SM; Rhee JS; Herzog E; Sigler A; Jahn R; Takamori S; Brose N; Rosenmund C
Proc Natl Acad Sci U S A; 2004 May; 101(18):7158-63. PubMed ID: 15103023
[TBL] [Abstract][Full Text] [Related]
40. The vesicular monoamine content regulates VMAT2 activity through Galphaq in mouse platelets. Evidence for autoregulation of vesicular transmitter uptake.
Höltje M; Winter S; Walther D; Pahner I; Hörtnagl H; Ottersen OP; Bader M; Ahnert-Hilger G
J Biol Chem; 2003 May; 278(18):15850-8. PubMed ID: 12604601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
